Baby Formula Makers Abbott and Reckitt See Stocks Slide

Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.
That baby formula trial Abbott and Reckitt had won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial
Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing the “widespread misconduct” of defendants Abbott Laboratories Inc. and Mead Johnson.
Pharma giants face new trial over infant formula
MISSOURI: A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialised baby formulas for premature infants, re-opening a case that had resulted in a victory for the defendants.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for injuries suffered by a child who consumed its formula designed for premature babies.
Reckitt still assessing options for Mead Johnson infant-formula “exit”
Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula business.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Citi sees overturned verdict in state case as incrementally negative for Abbott
Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...
Investing.com Canada16h
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
Investing.com - Reckitt Benckiser (LON: RKT) stock retreated Friday amid uncertainty over its liabilities surrounding its ...